Skip to main content

Immune plasma for immunoglobulin

  • Chapter
Supportive therapy in haematology
  • 92 Accesses

Abstract

Although the organisation of transfusion services varies from country to country, and indeed some countries remain partially or wholly dependent on commercial organisations for immunoglobulin products, there are certain common paths which all producers must follow.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hassig A, Lundsgaard-Hansen P: The procurement of blood and plasma for the production of components and derivatives within the frame of an integrated national blood program. Vox Sang, 1978; 34: 257–60.

    Article  PubMed  CAS  Google Scholar 

  2. Watt J: Epidemic hepatitis B caused by commercial human immunoglobulin. Lancet, 1979; 1: 1399–1400.

    Article  PubMed  CAS  Google Scholar 

  3. World Health Organisation. The collection, fractionation, quality control, and uses of blood and blood products. Geneva WHO, 1981.

    Google Scholar 

  4. Barker LF, Gerety RJ, Lorenz DE, Rastogi SC, Seligman EB: Biological standardization in viral hepatitis. In: Viral Hepatitis, Vyas GN, Cohen SN, Schmid R (eds). Philadelphia Franklin Institute Press, 1978: 581–87.

    Google Scholar 

  5. Zaia JA, Levin MJ, Preblud SR: The status of passive immunisation for herpes virus infections. In: Immunoglobulins: Characterisations and Uses of Intravenous Preparations, Alving BA, Finlayson JS (eds). United Sates Dept. of Health and Human Services, Washington D.C., 1980: 111–21.

    Google Scholar 

  6. Hejjas M, Salker R, Barbara JAJ: Screening blood donors for high titre antibody to herpes varicella zoster. Vox Sang, 1980; 39: 335–38.

    Article  PubMed  CAS  Google Scholar 

  7. Cuthbertson B: PhD thesis, University of Glasgow, 1982.

    Google Scholar 

  8. Barbara JAJ: In: Proceedings of the Second Hepatitis Workshop, Sirling, Scotland, 1— 3 September, 1982. Nuclear Enterprises 1983.

    Google Scholar 

  9. Crawford RJ: Immunoglobulin procurement. Biotest Bulletin, 1982; 1: 119–24.

    Google Scholar 

  10. World Health Organisation Memorandum. Appropriate use of human immunoglobulin in clinical practice. Bulletin of the World Health Organisation, 1982; 60: 43–47.

    Google Scholar 

  11. Crawford RJ: In: Proceedings of the Second Hepatitis Workshop, Stirling, Scotland, 1— 3 September, 1982. Nuclear Enterprises 1983.

    Google Scholar 

  12. Crawford RJ, Morgan M, Mitchell R: A regional programme to collect plasma for preparation of human immunoglobulin anti-rabies. J Clin Path, 1980; 33: 180–82.

    Article  PubMed  CAS  Google Scholar 

  13. Edsall G, Elliott MW, Peebles TC, Levine L, Eldred MC: Excessive use of tetanus toxoid boosters. JAMA, 1967; 202: 111–13.

    Article  PubMed  CAS  Google Scholar 

  14. Fisher MM: Pregnancy in anti-D donors. Lancet 1982; 2: 618.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers. Boston/Dordrecht/Lancaster

About this chapter

Cite this chapter

Crawford, R.J., Mitchell, R. (1985). Immune plasma for immunoglobulin. In: Das, P.C., Sibinga, C.T.S., Halie, M.R. (eds) Supportive therapy in haematology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2577-2_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2577-2_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9617-1

  • Online ISBN: 978-1-4613-2577-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics